Feasibility and ethical issues: experiences and concerns of healthcare workers regarding a new RSV prophylaxis programme in Nunavik, Quebec

Background: The respiratory syncytial virus (RSV) is a major cause of hospitalisation in young Inuit children. Prophylaxis with palivizumab is routinely recommended for premature infants and those with severe pulmonary or cardiac diseases. In the fall 2016, the Quebec Ministry of Health expanded the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorcy, Armelle, Gilca, Rodica, Dubé, Eve, Rochette, Marie, De Serres, Gaston
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144279/
https://www.ncbi.nlm.nih.gov/pubmed/32191589
http://dx.doi.org/10.1080/22423982.2020.1742564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144279/
https://www.ncbi.nlm.nih.gov/pubmed/32191589
http://dx.doi.org/10.1080/22423982.2020.1742564

Ejemplares similares